Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
Background Statins are the cornerstone of pharmacotherapy for atherosclerotic cardiovascular disease. While these drugs are generally safe, treatment adherence is not optimal in a considerable proportion of patients because of the adverse effects on skeletal muscles in the forms of myopathy, myalgia...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Wiley,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_20570d2b6cdd4ed6a8446b96d1e08dba | ||
042 | |a dc | ||
100 | 1 | 0 | |a Amirhossein Sahebkar |e author |
700 | 1 | 0 | |a Arrigo F.G. Cicero |e author |
700 | 1 | 0 | |a Paolo Di Giosia |e author |
700 | 1 | 0 | |a Irene Pomilio |e author |
700 | 1 | 0 | |a Cosimo Andrea Stamerra |e author |
700 | 1 | 0 | |a Paolo Giorgini |e author |
700 | 1 | 0 | |a Claudio Ferri |e author |
700 | 1 | 0 | |a Stephan vonHaehling |e author |
700 | 1 | 0 | |a Maciej Banach |e author |
700 | 1 | 0 | |a Tannaz Jamialahmadi |e author |
245 | 0 | 0 | |a Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system |
260 | |b Wiley, |c 2020-10-01T00:00:00Z. | ||
500 | |a 2190-6009 | ||
500 | |a 2190-5991 | ||
500 | |a 10.1002/jcsm.12579 | ||
520 | |a Background Statins are the cornerstone of pharmacotherapy for atherosclerotic cardiovascular disease. While these drugs are generally safe, treatment adherence is not optimal in a considerable proportion of patients because of the adverse effects on skeletal muscles in the forms of myopathy, myalgia, muscular pain, nocturnal muscle cramping, weakness, and rare rhabdomyolysis. Methods For the purpose of this narrative review, we searched for the literature suggesting the involvement of the ubiquitin-proteasome system in the development of statin-induced myopathy. Results Statins have been shown to up-regulate the expression of the muscle-specific ubiquitin-proteasome system as the major non-lysosomal intracellular protein degradation system. It has been postulated that statins may provoke instability in the myocyte cell membrane when subjected to eccentric exercise stress, triggering activation of intracellular proteolytic cascades and changes in protein degradation machinery. This is accompanied by the up-regulation of a series of genes implicated in protein catabolism, in addition to those of the ubiquitin-proteasome system. Conclusions Based on the available literature, it seems that the involvement of ubiquitin-proteasome system is potentially implicated in the pathophysiology of statin-induced myopathy. | ||
546 | |a EN | ||
690 | |a Statins | ||
690 | |a Myopathy | ||
690 | |a Ubiquitin‐proteasome system | ||
690 | |a Diseases of the musculoskeletal system | ||
690 | |a RC925-935 | ||
690 | |a Human anatomy | ||
690 | |a QM1-695 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 5, Pp 1177-1186 (2020) | |
787 | 0 | |n https://doi.org/10.1002/jcsm.12579 | |
787 | 0 | |n https://doaj.org/toc/2190-5991 | |
787 | 0 | |n https://doaj.org/toc/2190-6009 | |
856 | 4 | 1 | |u https://doaj.org/article/20570d2b6cdd4ed6a8446b96d1e08dba |z Connect to this object online. |